A Norwegian start-up, DoMore Diagnostics, is using AI to enhance the examination of colorectal cancer, allowing for more precise treatment decisions and potentially reducing unnecessary chemotherapy. The technology analyzes tissue samples in detail, outperforming human pathologists in predicting patient outcomes. This innovation aims to personalize cancer treatment and minimize toxic side effects for patients. Teljes cikk (Euronews.com)